Breast Tumor Characteristics as Predictors of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although mammographic screening is useful for detecting early breast cancer, some tumors are detected in the interval between screening examinations. This study attempted to characterize fully the tumors detected in the two different manners. METHODS: Our study utilized a case-control design and involved a cohort of women undergoing mammographic screening within the defined population of a health maintenance organization (the Group Health Cooperative of Puget Sound). Women were classified as having "interval" or "interval-detected" cancers (n = 150) if their diagnosis was made within 24 months after a negative-screening mammogram or one that indicated a benign condition. Cancers were classified as "screen detected" (n = 279) if the diagnosis occurred after a positive assessment by screening mammography. Tumors from women in each group were evaluated for clinical presentation, histology, proliferative characteristics, and expression of hormone receptors, p53 tumor suppressor protein, and c-erbB-2 protein. RESULTS: Interval-detected cancers occurred more in younger women and were of larger tumor size than screen-detected cancers. In unconditional logistic regression models adjusted for age and tumor size, tumors with lobular (odds ratio [OR] = 1.9; 95% confidence interval [CI] = 0.9-4.2) or mucinous (OR = 5.5; 95% CI = 1.5-19.4) histology, high proliferation (by either mitotic count [OR = 2.9; 95% CI = 1.5-5.7] or Ki-67 antigen expression [OR = 2.3; 95% CI = 1.3-4.1]), high histologic grade (OR = 2.1; 95% CI = 1.2-4.0), high nuclear grade (OR = 2.0; 95% CI = 1.0-3.7), or negative estrogen receptor status (OR = 1.8; 95% CI = 1.0-3.1) were more likely to surface in the interval between screening examinations. Tumors with tubular histology (OR = 0.2; 95% CI = 0.0-0.8) or with a high percentage of in situ components (50%) (OR = 0.5; 95% CI = 0.2-1.2) were associated with an increased likelihood of screen detection. CONCLUSIONS: Our data from a large group of women in a defined population indicate that screening mammography may miss tumors of lobular or mucinous histology and some rapidly proliferating, high-grade tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Bloom, H. J. G., & Richardson, W. W. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.43 · Cited by 2,925
Beahrs, O. H., & Henson, D. E. (1992) · Medical Entomology and Zoology · Cited by 2,460
Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase Transition
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., & Pagano, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2612 · Cited by 1,148
The Use of Antiavidin Antibody and Avidin-Biotin-Peroxidase Complex in Immunoperoxidase Technics
Hsu, S.-M., Raine, L., & Fanger, H. (1981) · American Journal of Clinical Pathology · doi:10.1093/ajcp/75.6.816 · Cited by 1,052
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
Self-citationNourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Cyclin-Dependent Regulation of G 1 in Mammalian Fibroblasts
Ohtsubo, M., & Roberts, J. M. (1993) · Science · doi:10.1126/science.8384376 · Cited by 756
Hsu, S. M., & Soban, E. (1982) · Journal of Histochemistry & Cytochemistry · doi:10.1177/30.10.6182185 · Cited by 659
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2843 · Cited by 353
Gerdes, J., Becker, M. H. G., Key, G., Cattoretti, G., Sanders, H. W., Smith, A. G., Crocker, J., Darnton, S. J., Gray, M. R., & Crocker, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680114 · Cited by 320
Breast cancer outcome and predictors of outcome: are there age differentials?
Albain, K. S., Allred, D. C., & Clark, G. M. (1994) · PubMed · Cited by 264
Age-dependent growth rate of primary breast cancer
Peer, P. G. M., van Dijck, J. A. A. M., Verbeek, A. L. M., Hendriks, J. H. C. L., & Holland, R. (1993) · Cancer · doi:10.1002/1097-0142(19930601)71:11<3547::aid-cncr2820711114>3.0.co;2-c · Cited by 263
Breast cancer missed by mammography
Martin, J., Moskowitz, M., & Milbrath (1979) · American Journal of Roentgenology · doi:10.2214/ajr.132.5.737 · Cited by 246
Effect of Estrogen Replacement Therapy on the Specificity and Sensitivity of Screening Mammography
Laya, M. B., Larson, E. B., Taplin, S. H., & White, E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.10.643 · Cited by 243
Self-citationKerlikowske, K. M. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.79 · Cited by 152
Ikeda, D. M., Andersson, I., Wattsgård, C., Janzon, L., & Linell, F. (1992) · American Journal of Roentgenology · doi:10.2214/ajr.159.2.1632342 · Cited by 151
Burhenne, H. J., Burhenne, L. J. W., Goldberg, F., Hislop, T. G., Worth, A. J., Rebbeck, P. M., & Kan, L. (1994) · American Journal of Roentgenology · doi:10.2214/ajr.162.5.8165983 · Cited by 122
A clinically effective breast cancer screening program can be cost-effective, too
Carter, A. P., Thompson, R. S., Bourdeau, R. V., Andenes, J., Mustin, H. D., & Straley, H. L. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90003-x · Cited by 55
Yakeishi, Y., Mori, M., & Enjoji, M. (1990) · Cancer · doi:10.1002/1097-0142(19900815)66:4<812::aid-cncr2820660436>3.0.co;2-1 · Cited by 39
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., et al. (2022) · The Breast · doi:10.1016/j.breast.2022.08.010 · Cited by 3,411
Mammographic Density and the Risk and Detection of Breast Cancer
Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062790 · Cited by 2,478
Kolb, T. M., Lichy, J., & Newhouse, J. H. (2002) · Radiology · doi:10.1148/radiol.2251011667 · Cited by 1,718
Metadata
- Authors
- Porter, P. L., El-Bastawissi, A. Y., Mandelson, M. T., Lin, M. G., Khalid, N., Watney, E. A., Cousens, L., White, D., Taplin, S., & White, E.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-12-01
- Volume
- 91
- Issue
- 23
- Pages
- 2020-2028
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2169422079
- Cited by
- 264
- References
- 21
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.